MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Today, cyber adversaries are not hacking in—they are logging in. Attackers primarily exploit weak, stolen, or compromised ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

Precision Biosciences' ARCUS platform offers high precision and versatility, supporting in vivo gene editing therapies, and ...

FREDERICK, Md., March 13, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune ...

One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

PARIS — Europe may have to wait for its own capability to suppress long-range enemy air defenses until at least 2033, with ...

Examples include chimeric antigen receptor (CAR) T cells for blood cancers, such as tisagenlecleucel (Kymriah) for acute lymphoblastic leukaemia, viral vectors that modify target cells to produce ...

As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead ...

HTX Research, the research arm of HTX Group, has released an in-depth report titled, "dTAO and the Evolution of Bittensor: Reshaping Decentralized AI with Market-Driven Incentives.". The evolution of ...

How the Spanish flag carrier, a major player in narrowbody engine maintenance, strives to expand its global reach.